ACRO BIOMEDICAL CO., LTD. 10-Q filing
Filed 2026-05-05 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001640334-26-000824
- Form type
- 10-Q
- CIK
- 0001622996
- Primary document
- https://www.sec.gov/Archives/edgar/data/1622996/000164033426000824/acbm_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ACRO BIOMEDICAL CO., LTD..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-60,271 | - | - |
| Net Income | $-43,774 | - | - |
| Eps Diluted | 0 | - | - |
| Total Assets | $3,873 | - | - |
| Shareholders Equity | $-427,235 | - | - |
| Operating Cash Flow | $-49,821 | - | - |